Form 4: Bausch Health Director Amy Wechsler Acquires Shares in Lieu of Cash Compensation

Director Amy Wechsler acquired 1,062 common shares of Bausch Health Companies Inc. in lieu of cash compensation for board service.

Summary

• On March 31, 2025, Amy Wechsler, a director of Bausch Health Companies Inc., acquired 1,062 common shares of the company.
• The shares were received in lieu of cash compensation for her service on the Issuer's Board of Directors for the quarter ending March 31, 2025.
• The price per share was $6.47.
• Following the transaction, Wechsler directly owns 209,008 common shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director taking shares in lieu of cash compensation suggests confidence in the company, but it's a routine transaction.

Positives

• A director taking shares in lieu of cash compensation can be seen as a positive signal, indicating confidence in the company's future performance.

Industry Context

Directors receiving shares as compensation is a common practice, aligning their interests with those of shareholders. This is a standard method of compensation for board members across the pharmaceutical and healthcare industries.

Comparison to Industry Standards

• Comparing Bausch Health's director compensation structure to companies like AbbVie, Johnson & Johnson, or Pfizer, it's common to see a mix of cash and equity-based compensation.
• Equity compensation is often used to align the interests of directors with the long-term performance of the company, similar to practices observed at Teva Pharmaceutical Industries and Mylan (now Viatris).

Stakeholder Impact

• The acquisition of shares by a director can have a slightly positive impact on shareholder confidence.

Key Dates

Keywords

Bausch Health, Director, Share Acquisition, Compensation, Form 4, Beneficial Ownership, Wechsler, BHC